C

Cambridge Enterprise

110 employees

Cambridge Enterprise helps the University of Cambridge's researchers & academics to commercialise their ideas for the benefit of society.

Investor insights

Sectors invested in

Biotechnology33
Health Care20
Software19
Machine Learning13
Information Technology12
Artificial Intelligence11
Life Science10
Medical9
Manufacturing7
Sensor6
Advanced Materials5
Pharmaceutical5
Electronics5
AI4
Research4
Genetics4
Therapeutics4
Biopharma4
Industrial4
Risk Modelling3

Funding rounds participated in

$3M sweet spot round size

Most of their 85 investments are in rounds between $1.7M and $5.7M

Investor type

University Program

Basic info

Industry

higher education

Sectors

Spinout company formation
Technology licensing
Education
University Seed Funding
Knowledge transfer
Commercialisation
Academic consultancy
Consultancy
Research impact
Knowledge exchange
University consulting
Consulting
Technology transfer
Intellectual Property
Entrepreneurship
Intellectual property
Innovation
Research commercialisation

Date founded

2006

Investments made

R

RoboK Limited raised $2M on June 29, 2023

Investors: Amadeus Capital Partners, The Bristol Port Company, Martlet Capital, u-blox, Deeptech Labs, Parkwalk Advisors and Cambridge Enterprise

U

Undisclosed raised $7.5M on May 22, 2023

Investors: MP Healthcare Venture Management Inc, Martlet Capital, o2h ventures, Wren Capital LLP, Parkwalk Advisors and Cambridge Enterprise

Z

Zetta Genomics Ltd raised $2.4M on April 17, 2023

Investors: Nina Capital and Cambridge Enterprise

I

Impossible Materials raised $3.8M on April 5, 2023

Investors: Inter IKEA Systems B.V., Apprecia Capital, EFI Lake Geneva Ventures, MissionPossible.VC, Big Idea Ventures and Cambridge Enterprise

K

Kalium Health raised $1.5M on November 9, 2022

Investors: Kidney Research UK, Martlet Capital and Cambridge Enterprise

C

Carbon Re raised $4.8M on November 7, 2022

Investors: UCL Technology Fund, Planet A Ventures, Clean Growth Fund and Cambridge Enterprise

P

Pretzel Therapeutics raised $73M on September 12, 2022

Investors: GU Ventures, Eir Ventures, The Invus Group, GV, Cambridge Innovation Capital plc, ARCH Venture Partners, HealthCap, Karolinska Development and Cambridge Enterprise

C

CardiaTec Biosciences LTD raised $1.7M on July 6, 2022

Investors: o2h ventures, Crista Galli Ventures, Laidlaw Scholars Ventures and Cambridge Enterprise

S

Spirea raised $2.9M on June 14, 2022

Investors: Cambridge Angels, ACF Investors, R42 Group, o2h ventures and Cambridge Enterprise

C

ConcR raised $1.5M on May 1, 2022

Investors: Cambridge Angels, R42 Group and Cambridge Enterprise

FAQ